JNJ — JOHNSON & JOHNSON
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 200406 ·
Last close
$260.86
Market Cap
$628.65B
52W High
$274.90
52W Low
$220.84
ADV30
7,676,304
Next earnings
2026-10-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 24,062,000,000 | 15,956,000,000 | 6,395,000,000 | 5,235,000,000 | 200,894,000,000 | 21,688,000,000 | 119,708,000,000 |
| Dec 2025 | 24,564,000,000 | 16,596,000,000 | 5,591,000,000 | 5,116,000,000 | 199,210,000,000 | 19,709,000,000 | 117,666,000,000 |
| Sep 2025 | 23,993,000,000 | 16,690,000,000 | 7,096,000,000 | 5,152,000,000 | 192,816,000,000 | 18,231,000,000 | 113,539,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$27,608,000,000
Investing CF
$-7,177,000,000
Financing CF
$-18,543,000,000
CapEx
$-5,380,000,000
Dividends Paid
$-12,621,000,000
Buybacks
$-8,075,000,000
EPS Diluted TTM
$8.63
As of
2026-07-26
Balance + Analyst (yfinance extras)
Retained Earnings
—
Inventory
$15,144,000,000
Receivables
$19,046,000,000
ST Investments
$336,000,000
EBIT TTM
$26,208,000,000
Pretax Income TTM
$25,196,000,000
Interest Exp TTM
$1,012,000,000
Analysts
22
Yahoo Snapshot (yfinance, live)
Total Revenue
$97,929,003,008
EBITDA
$34,872,000,512
Free Cash Flow
$16,885,125,120
Enterprise Value
$656,924,147,712
Total Cash
$20,757,999,616
Total Debt
$49,036,001,280
Shares Out
2,409,898,597
Trailing EPS
$8.66
Book Value
$35.28
ROE
25.7%
ROA
8.6%
Div Yield
2.06%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 94,193,000,000 | 25,596,000,000 | 26,804,000,000 | 199,210,000,000 | 117,666,000,000 | — | 24,530,000,000 |
| Dec 2024 | 88,821,000,000 | 21,249,000,000 | 14,066,000,000 | 180,104,000,000 | 108,614,000,000 | — | 24,266,000,000 |
| Dec 2023 | 85,159,000,000 | 22,009,000,000 | 35,153,000,000 | 167,558,000,000 | 98,784,000,000 | — | 22,791,000,000 |
| Dec 2022 | 79,990,000,000 | 21,013,000,000 | 17,941,000,000 | 187,378,000,000 | 110,574,000,000 | — | 21,194,000,000 |
TTM Snapshot
Revenues TTM
$87,156,000,000
NetIncome TTM
$36,847,000,000
OpCashFlow TTM
$0
Assets (Latest)
$180,104,000,000
Forward EPS
$12.31
Max Pain — expiry 2026-08-21
max pain strike: $252.50 · spot: $261.30 · call oi: 40,781 · put oi: 26,193
Expected Move to 2026-08-21:
±$6.57
(2.51%) —
implied range
$254.73 –
$267.87
· ATM straddle on $262.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ABBV | AbbVie Inc. | $439.59B | $248.76 | — |
| LLY | ELI LILLY & Co | $1.09T | $1220.28 | — |
| MRK | Merck & Co., Inc. | $327.94B | $132.92 | — |
| NVSEF | NOVARTIS AG | $300.12B | $157.90 | — |
| NVS | NOVARTIS AG | $289.52B | $152.32 | — |
News headlines (Yahoo Finance, 1h cache)
Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested Pays Annually.
2026-08-13 19:12 · Yahoo
The Sharpest Exchanges From ABBV's Earnings Call
2026-08-13 16:10 · Yahoo
MeiraGTx Reports Second Quarter 2026 Financial and Operational Results
2026-08-13 12:00 · Yahoo
The Paid-To-Hold Play On ISRG Stock: A 12% Annualized Income
2026-08-12 21:37 · Yahoo
Intuitive Surgical (ISRG) Beats On Q2 As Investors Ask If The Bull Case Is Priced In
2026-08-12 21:13 · Yahoo
How ABBV Stock Moved Away From Its Peer Group
2026-08-12 20:49 · Yahoo
Amgen Stock And The Price Of A Promise
2026-08-12 19:17 · Yahoo
Johnson & Johnson vs AbbVie: Safe Dividend vs Higher Yield
2026-08-12 18:30 · Yahoo
Two Years Of Growth Barely Change What You Pay For Intuitive Surgical
2026-08-12 17:20 · Yahoo
The Energy and Pharma Giants Quietly Funding HDV’s 3% Yield, and How Safe Each One Is
2026-08-12 16:12 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.